Morgan Stanley Call 220 DYH 17.01.../ DE000MB37FY9 /
2024-05-29 11:22:00 AM | Chg.+0.005 | Bid12:48:18 PM | Ask12:48:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.056EUR | +9.80% | 0.058 Bid Size: 5,000 |
0.074 Ask Size: 5,000 |
TARGET CORP. DL-... | 220.00 - | 2025-01-17 | Call |
GlobeNewswire
1:02 PM
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
1:00 PM
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire
1:00 PM
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
1:00 PM
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire
1:00 PM
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire
1:00 PM
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire
1:00 PM
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire
1:00 PM
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire
1:00 PM
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
GlobeNewswire
1:00 PM
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaki...